Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy. Photo via unsplash.com

Health care executive Benjamin Foster knows that nurses are essential — especially in times of crisis.

In 2017, when Hurricane Harvey struck Houston, he watched as local health care organizations struggled to find nurses who could meet the desperate need at hard-to-reach facilities. And as Regional Chief Human Resources Officer at HCA Houston Healthcare, he had also grown accustomed to the high costs and inefficiencies of traditional medical staffing agencies.

In 2020, in response to the demand for nurses in the pandemic, he decided it was time to act, launching Nurseify in May of that year.

Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy.With guidance from Rama Walker, Nurseify’s Chief Nursing Officer and Chief Operating Officer with a background in ER administration, the platform uses AI to match nurses with facilities looking to fill short-term assignments.

Nurses are able to set their rates and schedules through the app. Health care facilities can directly vet applicants through their profiles and ratings. The platform also can predict when there might be a higher demand for contract nurses at various facilities based on vacancies and increased patient volume.

“We hope to empower nurses and help individuals take control of their careers by offering transparency and a way to create schedules to better fit their lifestyles,” says Foster, CEO of Nurseify, in a statement. “In this gig-economy, it’s imperative to have an easy and effective way for nurses and healthcare facilities to communicate directly about opportunities, and Nurseify provides a place where they can do just that.”

Additionally, the platform features educational, financial, and support resources for nurse users, as well as options to work with entrepreneurial mentors and wellness coaches with the goal of empowering nurses in what's proven to be a demanding field, especially since the onset of the pandemic.

“As nurse advocates, we prioritize an honest hiring process and nurses’ work-life balance and overall wellbeing,” Walker adds in a statement.

According to the Nurseify team, more than 5,000 nurses have created profiles on the platform at press time; and 60 healthcare facilities have access to Nurseify.

Through the Nuresify mobile app, which launches in May, the company aims to attract more users and health care facilities.

Currently the company is focused on its operations in Texas, Georgia, Florida, and South Carolina, which were pilot states for Nurseify. But the company aims to expand nationally and internationally in the future.

Houston-based acute care startup Kare Technologies launched a similar platform for staffing within the senior living facility and caregiving realms in 2021. Read more about that company here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

Houston investment firm names tech exec as new partner

new hire

Houston tech executive Robert Kester has joined Houston-based Veriten, an energy-focused research, investment and strategy firm, as technology and innovation partner.

Kester most recently served as chief technology officer for emissions solutions at Honeywell Process Solutions, where he worked for five years. Honeywell International acquired Houston-based oil and gas technology company Rebellion Photonics, where Kester was co-founder and CEO, in 2019.

Honeywell Process Solutions shares offices in Houston with the global headquarters of Honeywell Performance Materials and Technologies. Honeywell, a Fortune 100 conglomerate, employs more than 850 people in Houston.

“We are thrilled to welcome Robert to the Veriten team,” founder and CEO Maynard Holt said in a statement, “and are confident that his technical expertise and skills will make a big contribution to Veriten’s partner and investor community. He will [oversee] every aspect of what we do, with the use case for AI in energy high on the 2025 priority list.”

Kester earned a doctoral degree in bioengineering from Rice University, a master’s degree in optical sciences from the University of Arizona and a bachelor’s degree in laser optical engineering technology from the Oregon Institute of Technology. He holds 25 patents and has more than 25 patents pending.

Veriten celebrated its third anniversary on January 10, the day that the hiring of Kester was announced. The startup launched with seven employees.

“With the addition of Dr. Kester, we are a 26-person team and are as enthusiastic as ever about improving the energy dialogue and researching the future paths for energy,” Holt added.

Kester spoke on the Houston Innovators Podcast in 2021. Listen here

.